scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00259-014-2936-Y |
P8608 | Fatcat ID | release_hurcwxgi7rda5f6mlvmflhvskq |
P698 | PubMed publication ID | 25331460 |
P5875 | ResearchGate publication ID | 267210384 |
P50 | author | Thierry Billard | Q47159858 |
Luc Zimmer | Q56977691 | ||
Véronique Sgambato-Faure | Q64856224 | ||
P2093 | author name string | Léon Tremblay | |
Guillaume Becker | |||
Julie Colomb | |||
P2860 | cites work | Synthesis and in vivo evaluation of [O-methyl-11C] N-[3,5-dichloro-2-(methoxy)phenyl]-4-(methoxy)-3-(1-piperazinyl)benzenesulfonamide as an imaging probe for 5-HT6 receptors | Q48960062 |
Syntheses, radiolabelings, and in vitro evaluations of fluorinated PET radioligands of 5-HT6 serotoninergic receptors. | Q51749116 | ||
Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor | Q24310557 | ||
Characterization of [(125)I]-SB-258585 binding to human recombinant and native 5-HT(6) receptors in rat, pig and human brain tissue | Q24674871 | ||
5-ht6 receptors | Q28245286 | ||
A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation | Q28263452 | ||
Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system | Q28303834 | ||
Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs | Q28580751 | ||
5-ht6 receptors as emerging targets for drug discovery | Q33904014 | ||
The highly permeable blood-brain barrier: an evaluation of current opinions about brain uptake capacity | Q34008585 | ||
The distribution of 5-HT(6) receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]SB-258585. | Q34122424 | ||
5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585. | Q34138219 | ||
5-HT6 receptor ligands and their antipsychotic potential | Q34165258 | ||
Serotonin receptors in the human brain--IV. Autoradiographic mapping of serotonin-2 receptors | Q34185204 | ||
Highlighting the Versatility of the Tracerlab Synthesis Modules. Part 1: Fully Automated Production of [F]Labelled Radiopharmaceuticals using a Tracerlab FX(FN). | Q35108246 | ||
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7). | Q35162302 | ||
Determination of lipophilicity and its use as a predictor of blood-brain barrier penetration of molecular imaging agents | Q35604800 | ||
PET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS. | Q35768641 | ||
5-HT6 receptors: a novel target for cognitive enhancement | Q36187762 | ||
Using positron emission tomography to facilitate CNS drug development | Q36470266 | ||
Small-animal positron emission tomography as a tool for neuropharmacology | Q37769735 | ||
5-HT6 pharmacology inconsistencies | Q37824730 | ||
The central role of 5-HT6 receptors in modulating brain neurochemistry | Q37844221 | ||
The 5-HT6 receptor as a target for developing novel antiobesity drugs | Q37844227 | ||
5-HT6 receptor ligands as antidementia drugs. | Q37844230 | ||
PET radiotracers for molecular imaging in the brain: past, present and future | Q37973630 | ||
5-HT6 receptor antagonists as treatment for age-related cognitive decline | Q38195492 | ||
A multi-atlas based method for automated anatomical Macaca fascicularis brain MRI segmentation and PET kinetic extraction | Q40101472 | ||
Differences in the central nervous system distribution and pharmacology of the mouse 5-hydroxytryptamine-6 receptor compared with rat and human receptors investigated by radioligand binding, site-directed mutagenesis, and molecular modeling | Q40611704 | ||
The 5-hydroxytryptamine6 receptor-selective radioligand [3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum. | Q42539853 | ||
Radiosynthesis and characterization of 11C-GSK215083 as a PET radioligand for the 5-HT6 receptor. | Q42722533 | ||
Biodistribution and radiation dosimetry of the serotonin 5-HT₆ ligand [¹¹C]GSK215083 determined from human whole-body PET. | Q45110152 | ||
Cyclosporine, a P-glycoprotein modulator, increases [18F]MPPF uptake in rat brain and peripheral tissues: microPET and ex vivo studies | Q46499243 | ||
Synthesis and biological evaluation in rat and cat of [18F]12ST05 as a potential 5-HT6 PET radioligand | Q46903356 | ||
P433 | issue | 3 | |
P1104 | number of pages | 8 | |
P304 | page(s) | 495-502 | |
P577 | publication date | 2014-10-21 | |
P1433 | published in | European Journal of Nuclear Medicine and Molecular Imaging | Q15708890 |
P1476 | title | Preclinical evaluation of [18F]2FNQ1P as the first fluorinated serotonin 5-HT6 radioligand for PET imaging | |
P478 | volume | 42 |